Citi lowered the firm’s price target on DocuSign (DOCU) to $110 from $115 and keeps a Buy rating on the shares. After a strong finish last year, DocuSign’s Q1 results “were a frustrating set-back” with a true billings miss due to go-to-market changes driving fewer early renewals than anticipated, the analyst tells investors in a research note. The firm says the good news is DocuSign’s execution shortfall appears mostly timing-related.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCU:
- DocuSign’s Earnings Call: Strong Growth Amid Caution
- DocuSign’s Stock Tumbles Amid Analyst Caution
- U.S. payrolls rise 139,000, Broadcom reports Q2 beat: Morning Buzz
- DocuSign price target lowered to $85 from $88 at BofA
- Morning Movers: Manchester United gains, Lululemon sinks after quarterly reports